Product: Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059.  NDC:  69097-870-67
Reason for recall: Presence of Particulate Matter.
Recall initiated: 20260102
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated